Filing Details
- Accession Number:
- 0000874015-12-000058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-06 21:39:45
- Reporting Period:
- 2012-09-04
- Filing Date:
- 2012-09-06
- Accepted Time:
- 2012-09-06 21:39:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1181561 | C John Reed | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-09-04 | 5,100 | $5.17 | 5,100 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-09-04 | 5,100 | $15.17 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-09-06 | 4,900 | $5.17 | 4,900 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-09-06 | 4,900 | $15.18 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Director Stock Option (right to buy) | Disposition | 2012-09-04 | 5,100 | $0.00 | 5,100 | $5.17 |
Common Stock | Director Stock Option (right to buy) | Disposition | 2012-09-06 | 4,900 | $0.00 | 4,900 | $5.17 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,900 | 2007-07-01 | 2013-06-30 | No | 4 | M | Direct |
0 | 2007-07-01 | 2013-06-30 | No | 4 | M | Direct |
Footnotes
- Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 10/3/2011.